EUVIMEDEUVIMED entdecken
Crossref

ARF1 is Correlated with AKT and Poor Survival, and Its Inhibition Represses Cell Proliferation and Invasion via the AKT Pathway in Hepatocellular Carcinoma

Jie Li, Tingting Gao, Xiangyang He, Qingjun Zhang, Xu Han

The Tohoku Journal of Experimental Medicine · 2026

DOI: 10.1620/tjem.2026.j036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2026. Verfasst von Jie Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Zibo Central Hospital. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proto-Oncogene Proteins c-akt, ADP-Ribosylation Factor 1. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine diphosphate-ribosylation factor 1 (ARF1), which was recently reported to be a tumor-promoting factor, regulates intracellular transport and maintains trafficking homeostasis. This study aimed to investigate ARF1 dysregulation and its correlation with AKT and survival in hepatocellular carcinoma (HCC) patients and the effects of ARF1 inhibition via the AKT pathway on HCC cell functions. ARF1 expression in tumor tissues and its connection with overall survival and AKT in HCC patients were analyzed via the Gene Expression Profiling Interactive Analysis, Human Protein Atlas, and STRING databases. HCC cells (HUH-7 and MHCC-97H) were nontransfected or transfected with ARF1 siRNA or negative control siRNA; then, 740Y-P was added for AKT pathway activation. Cell proliferation, apoptosis, invasion, and the AKT pathway were detected. ARF1 was upregulated in HCC tissues compared with normal tissues, and its high expression was correlated with unsatisfactory overall survival in HCC patients. ARF1 was positively correlated with AKT in HCC tissues, and a possible connection between ARF1 and AKT, both directly and indirectly, was discovered via protein-protein interaction analysis. ARF1 inhibition reduced cell proliferation and invasion significantly, induced cell apoptosis to some extent, and inactivated the AKT pathway in HCC cells. Moreover, AKT pathway activation attenuated the effects of ARF1 inhibition on the proliferation, apoptosis, and invasion of HCC cells. Collectively, ARF1 is upregulated and may correlate with AKT and shorter survival, and ARF1 inhibition tends to repress cell proliferation and invasion via the AKT pathway in HCC, suggesting that ARF1 might be a potential target for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsProto-Oncogene Proteins c-aktADP-Ribosylation Factor 1Signal TransductionHumansCell ProliferationNeoplasm InvasivenessCell Line, TumorApoptosisFemaleGene Expression Regulation, NeoplasticMaleSurvival AnalysisCell MovementMiddle Aged

Stichwörter der Autor:innen

AKT pathwayARF1cell functionsclinical valuehepatocellular carcinoma

Substanzen

Proto-Oncogene Proteins c-aktADP-Ribosylation Factor 1ARF1 protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Zibo Central Hospital.

Zitieren

APA

Li, J., Gao, T., He, X., Zhang, Q., & Han, X. (2026). ARF1 is Correlated with AKT and Poor Survival, and Its Inhibition Represses Cell Proliferation and Invasion via the AKT Pathway in Hepatocellular Carcinoma. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2026.j036

Vancouver

Li J, Gao T, He X, Zhang Q, Han X. ARF1 is Correlated with AKT and Poor Survival, and Its Inhibition Represses Cell Proliferation and Invasion via the AKT Pathway in Hepatocellular Carcinoma. The Tohoku Journal of Experimental Medicine. 2026. doi:10.1620/tjem.2026.j036

BibTeX
@article{Li2026,
  author = {Li, Jie and Gao, Tingting and He, Xiangyang and Zhang, Qingjun and Han, Xu},
  title = {ARF1 is Correlated with AKT and Poor Survival, and Its Inhibition Represses Cell Proliferation and Invasion via the AKT Pathway in Hepatocellular Carcinoma},
  journal = {The Tohoku Journal of Experimental Medicine},
  year = {2026},
  doi = {10.1620/tjem.2026.j036}
}
Kostenlos starten →